{"&cites=14219812270129551750&as_sdt=2005&sciodt=0,5&hl=en":[{"title":"Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP)","url":"https://www.sciencedirect.com/science/article/pii/S016164201300331X","authors":["S Rofagha","S Rofagha RB Bhisitkul","S Rofagha RB Bhisitkul DS Boyer","S Rofagha RB Bhisitkul DS Boyer SVR Sadda…"],"year":2013,"numCitations":681,"pdf":"https://www.aaojournal.org/article/S0161-6420(13)00331-X/fulltext","citationUrl":"http://scholar.google.com/scholar?cites=946984648950578562&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:gn1yWIVdJA0J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=946984648950578562&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier","p":1,"exp":1596899208730},{"title":"Intravitreal aflibercept for diabetic macular edema","url":"https://www.sciencedirect.com/science/article/pii/S0161642014004266","authors":["JF Korobelnik","JF Korobelnik DV Do","JF Korobelnik DV Do U Schmidt"],"year":2014,"numCitations":634,"pdf":"https://www.aaojournal.org/article/S0161-6420(14)00426-6/fulltext","citationUrl":"http://scholar.google.com/scholar?cites=1240426787840691176&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:6Isfa5fhNhEJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=1240426787840691176&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six–week results of the VIEW studies","url":"https://www.sciencedirect.com/science/article/pii/S016164201300729X","authors":["U Schmidt"],"year":2014,"numCitations":588,"pdf":"https://www.aaojournal.org/article/S0161-6420(13)00729-X/fulltext","citationUrl":"http://scholar.google.com/scholar?cites=18165747400033048670&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:XhhymgOzGfwJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=18165747400033048670&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial","url":"https://www.sciencedirect.com/science/article/pii/S0140673613615019","authors":["U Chakravarthy","U Chakravarthy SP Harding","U Chakravarthy SP Harding CA Rogers","U Chakravarthy SP Harding CA Rogers SM Downes…"],"year":2013,"numCitations":581,"pdf":"https://www.sciencedirect.com/science/article/pii/S0140673613615019","citationUrl":"http://scholar.google.com/scholar?cites=4406819954534910838&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:dgsoe2YrKD0J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=4406819954534910838&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Aptamers as targeted therapeutics: current potential and challenges","url":"https://www.nature.com/nrd/journal/v16/n3/full/nrd.2016.199.html","authors":["J Zhou","J Zhou J Rossi"],"year":2017,"numCitations":554,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5700751/","citationUrl":"http://scholar.google.com/scholar?cites=15074732098699381405&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:nconc_k0NNEJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=15074732098699381405&hl=en&as_sdt=2005&sciodt=0,5","publication":"nature.com"},{"title":"Ten years of anti-vascular endothelial growth factor therapy","url":"https://www.nature.com/nrd/journal/v15/n6/full/nrd.2015.17.html","authors":["N Ferrara","N Ferrara AP Adamis"],"year":2016,"numCitations":388,"pdf":"https://escholarship.org/content/qt8fc8m0vp/qt8fc8m0vp.pdf","citationUrl":"http://scholar.google.com/scholar?cites=16299837297661969012&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:dALOd6mnNOIJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=16299837297661969012&hl=en&as_sdt=2005&sciodt=0,5","publication":"nature.com"},{"title":"Five-year outcomes with anti–vascular endothelial growth factor treatment of neovascular age-related macular degeneration: the Comparison of Age-Related Macular …","url":"https://www.sciencedirect.com/science/article/pii/S0161642016300926","authors":["MG Maguire","MG Maguire DF Martin","MG Maguire DF Martin G Ying","MG Maguire DF Martin G Ying GJ Jaffe","MG Maguire DF Martin G Ying GJ Jaffe E Daniel…"],"year":2016,"numCitations":301,"pdf":"https://www.aaojournal.org/article/S0161-6420(16)30092-6/fulltext","citationUrl":"http://scholar.google.com/scholar?cites=9387167101293214491&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:G7vQR77qRYIJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=9387167101293214491&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)","url":"https://bjo.bmj.com/content/98/9/1144.short","authors":["U Schmidt"],"year":2014,"numCitations":277,"pdf":"https://bjo.bmj.com/content/bjophthalmol/98/9/1144.full.pdf","citationUrl":"http://scholar.google.com/scholar?cites=17377900311889608752&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:MIBU-EK0KvEJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=17377900311889608752&hl=en&as_sdt=2005&sciodt=0,5","publication":"bjo.bmj.com"},{"title":"Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab","url":"https://www.sciencedirect.com/science/article/pii/S000293941300144X","authors":["B Bakall","B Bakall JC Folk","B Bakall JC Folk HC Boldt","B Bakall JC Folk HC Boldt EH Sohn","B Bakall JC Folk HC Boldt EH Sohn EM Stone…"],"year":2013,"numCitations":257,"pdf":"https://www.academia.edu/download/40341351/Aflibercept_Therapy_for_Exudative_Age-re20151124-4058-j0vk9f.pdf","citationUrl":"http://scholar.google.com/scholar?cites=7227964682106448714&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:SisGPpXjTmQJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=7227964682106448714&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Ocular neovascularization","url":"https://link.springer.com/content/pdf/10.1007/s00109-013-0993-5.pdf","authors":["PA Campochiaro"],"year":2013,"numCitations":251,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584193/","citationUrl":"http://scholar.google.com/scholar?cites=15356293071445531673&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:GZxN9i-DHNUJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=15356293071445531673&hl=en&as_sdt=2005&sciodt=0,5","publication":"Springer"}]}